Vitreoretinal interface abnormalities in diabetic macular edema and effectiveness of anti-VEGF therapy: an optical coherence tomography study

Macular Diseases

Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface

Am J Ophthalmol.

Hagenau F, Vogt D, Ziada J, Guenther SR, Haritoglou C, Wolf A, Priglinger SG, Schumann RG

doi: 10.1016/j.ajo.2018.12.004.

Macular DiseasesRetinal Diseases

PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY

Retina.

Fickweiler W, Schauwvlieghe AM, Schlingemann RO, Maria Hooymans JM, Los LI, Verbraak FD; BRDME Research Group

doi: 10.1097/IAE.

Macular Diseases

Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

Am J Ophthalmol.

Felfeli T, Juncal VR, Hillier RJ, Mak MY, Wong DT, Berger AR, Kohly RP, Kertes PJ, Eng K, Boyd SR, Altomare F, Giavedoni LR, Muni RH

doi: 10.1016/j.ajo.

COMMENTED

Macular Diseases

Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting

Am J Ophthalmol.

Maggio E, Sartore M, Attanasio M, Maraone G, Guerriero M, Polito A, Pertile G

doi: 10.1016/j.ajo.2018.08.004.

COMMENTED

Macular Diseases

Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice

Ophthalmology.

Maloney MH, Schilz SR, Herrin J, Sangaralingham LR, Shah ND, Barkmeier AJ

doi: 10.1016/

Macular Diseases

Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers

Acta Ophthalmol.

Bonfiglio V, Reibaldi M, Pizzo A, Russo A, Macchi I, Faro G, Avitabile T, Longo A

doi: 10.1111/aos.13935.

Glaucoma and Ocular PressureMacular DiseasesOcular OncologyRetinal Diseases

Pseudophakic Macular Edema in Primary Open-Angle Glaucoma: a Prospective Study Using Spectral-Domain Optical Coherence Tomography

Am J Ophthalmol.

Lee KM, Lee EJ, Kim TW, Kim H

doi: 10.1016/j.ajo.2017.05.001.

Retinal Diseases

Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study

Eur J Ophthalmol.

Furino C, Di Antonio L, Grassi MO, Rispoli M, Reibaldi M, Niro A, Alessio G

doi: 10.1177/1120672118792187.

Macular Diseases

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES AFTER SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA

Retina.

Vujosevic S, Gatti V, Muraca A, Brambilla M, Villani E, Nucci P, Rossetti L, De Cillaʼ S

doi: 10.1097/IAE.

Related content

Vitrectomy for diabetic macular edema: optical coherence tomography criteria and pathology of the vitreomacular interface

PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY

Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema

Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting

Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice

Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers

Pseudophakic Macular Edema in Primary Open-Angle Glaucoma: a Prospective Study Using Spectral-Domain Optical Coherence Tomography

Choroidal neovascularization due to choroidal osteoma treated with anti-vascular endothelial growth factor therapy: An optical coherence tomography angiography study

OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES AFTER SUBTHRESHOLD MICROPULSE YELLOW LASER IN DIABETIC MACULAR EDEMA